Biohit Oyj stock exchange release 28[th] of June 2021 at 02.00 pm local time
(EET)
Changes in management team
Biotechnology and food engineer, Production Manager Suvi Elomaa starts on 1[st]
of July as Biohit's Production Director and part of the Management Team. Suvi
Elomaa has worked at Biohit since 2013.
Microbiologist and computer science engineer (p.hD.) Minna Mäki continues as
company’s R&D Director and part of the Management Team. The change is part of
Biohit's operational development program.
Additional information:
Deputy CEO Osmo Suovaniemi, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit mission
is “Innovating for Health” – we produce innovative products and services to
promote research and early diagnosis. Biohit is headquartered in Helsinki,
Finland, and has subsidiaries in Italy and the UK. Biohit Series B share (BIOBV)
is quoted on Nasdaq Helsinki in the Small cap/Healthcare group.
www.biohithealthcare.com (https://www.globenewswire.com/Tracker?data=ciyb_iZ945H2
z3sK3a9i7Zs03Nkj9jr5Brw7kC1tsoUye5PVgko06PC57Z9BVVT2pXUgp6sn
-tswLd2MUgQOQc8UNXD2BkNm3L02XzRJ7XfJCPaPUqGS1mpI0NZinK5T)